跳至主要内容
临床试验/EUCTR2012-004103-12-FR
EUCTR2012-004103-12-FR进行中(未招募)不适用

ISOTOVE studyIsotopic study of the intraperitoneal distribution of locoregional post surgery chemotherapy for peritoneal carcinomatosis of ovarian origin

Centre Jean Perrin0 个研究点开始时间: 2013年6月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Age> 18 years.
  • -Performance status 0-2
  • - ANC> 1.5.109 / L (without the addition of GCSF)
  • -Platelets> 100. 109 / L
  • -Bilirubin -AST and ALT Alkaline-Phosphatase - Creatinine -PTT <1.5 times the upper normal value (heparin, or other anticoagulants lovenox accepted)
  • -PT/INR - Patient operated first line without macroscopic residue for ovarian cancer or primary peritoneal or tubal stage IIIC peritoneal or pleural IV
  • -Minimum required for surgery: hysterectomy, bilateral salpingo-oophorectomy, omentectomy and pelvic lymphadenectomy para-aortic
  • - Patient requiring adjuvant chemotherapy
  • - Compulsory affiliation to a social security scheme.
  • - Obtaining informed consent in writing, signed and dated.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • -Patient aged 70 years and over
  • - Patient with cognitive or psychiatric conditions.
  • - Patient deprived of liberty by a court or administrative order.
  • - Patient with indications against the realization of chemotherapy
  • - Concomitant treatment with a drug test, participation in another therapeutic clinical trial < 30 days
  • - Pregnant Women
  • - Breastfeeding
  • Sensory neuropathy, motor or > grade 1 (CTCAE)
  • -Hepatitis or severe infection requiring parenteral antibiotics
  • - Serious non-healing wound or ulcer, or bone fracture
  • -Abdominal fistula or gastrointestinal perforation, or intra-abdominal abscess within 28 days prior to intraperitoneal chemotherapy
  • -Clinical symptoms or signs of gastrointestinal obstruction and / or require hydration and / or parenteral nutrition
  • -Patients who have had or are currently having an inflammatory disease of the bowel
  • - Active bleeding or pathological condition that carries a high risk of bleeding (eg, bleeding disorders known coagulopathy, or tumor with large vessels)
  • - Stroke (CVA) or transient ischemic attack, or subarachnoid hemorrhage within the past 6 months
  • - Cardiovascular disease clinically significant, including:
  • o Uncontrolled hypertension, defined as systolic blood pressure> 150 mm Hg or diastolic> 90 mm Hg
  • o myocardial infarction or unstable angina within the past 6 months
  • o NYHA class II-IV congestive heart failure
  • o serious cardiac arrhythmia requiring treatment:
  • -Asymptomatic atrial fibrillation with controlled ventricular or supraventricular tachycardia controlled with medication and is authorized asymptomatic
  • o Peripheral vascular disease = grade 2 (CTCAE) (short [less than 24 hours] episodes of ischemia managed non-surgically and without permanent deficit)
  • -History hemorrhage or cerebral vascular accident (CVA), transient ischemic attack, or subarachnoid in the last 6 months
  • -Major surgery within 28 days before enrollment

研究者

发起方
Centre Jean Perrin

相似试验

ISOTOVE studyIsotopic study of the intraperitoneal... | 临床试验